Table II.

Distribution of HLA-DQB1 alleles among control, AMAN and AIDP cases, and C. jejuni seropositive and seronegative patients

AllelesControlAMANAIDP
n (97)%n (46)%Sero +Sero −n (23)%Sero +Sero −
DQB1*020166.36135128.611
DQB1*02022425.2817.343a28.601a
DQB1*03014143.11634.787a939.127
DQB1*030299.424.320417.313
DQB1*03032829.41021.754a730.413a
DQB1*03041100.00000.000
DQB1*040166.361314a521.723
DQB1*040222.124.30228.601a
DQB1*05011111.524.31131303
DQB1*050299.46133331302a
DQB1*050377.348.611a14.301
DQB1*06011414.7919.55428.602
DQB1*06021920919.562a14.301
DQB1*060322.124.31100.000
DQB1*06041112.11000.000
DQB1*060500.012.10000.000
DQB1*060900.012.10000.000
  • a The number of individuals characterized for seroreactivity to C. jejuni may not necessarily add to the number of individuals with the particular allele due to the fact that not all HLA-typed cases were characterized for seroreactivity against C. jejuni.